Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intellimedix

Intellimedix
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$2.3M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of novel technologies and approaches to accelerate the discovery of new treatments for neurological diseases. The company analyzes mutations in human genes to identify the diseases a person might have a propensity to develop and suggest compounds (both existing and new) that may be effective in treating the disease.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Primary Office
  • 171 17th. Street
  • Suite 1525
  • Atlanta, GA 30363
  • United States

+1 (770) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Intellimedix’s full profile, request a free trial.

Intellimedix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Feb-2015 $2.3M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Intellimedix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Chris Klaus Angel (individual) Minority 000 0000 000000 0
Jim Jacoby Angel (individual) Minority 000 0000 000000 0
NeuroLaunch Accelerator/Incubator Minority 000 0000 000000 0

Intellimedix Executive Team (5)

Name Title Board
Seat
Contact
Info
Jim Richards President & Chief Executive Officer
Jim Jacoby Chairman & Founder
Jeffrey Skolnick Ph.D Chief Scientific Officer

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »

Intellimedix Board Members (1)

Name Representing Role Since Contact
Info
Jim Jacoby Intellimedix Chairman & Founder 000 0000